Latest Articles

Publication Date
All News Scientific
Merck’s Sac-TMT met primary endpoints in endometrial cancer trial - TipRanks

Merck’s Sac-TMT met primary endpoints in endometrial cancer trial TipRanks

Published: May 18, 2026, 11:10 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Primary Periumbilical Endometriosis Mimicking Umbilical Hernia in a 37-Year-Old Woman: A Report of a Rare Case - Cureus

Primary Periumbilical Endometriosis Mimicking Umbilical Hernia in a 37-Year-Old Woman: A Report of a Rare Case Cureus

Published: May 9, 2026, 10:09 a.m.
Read Full Article
Phenotypic and Functional Characterisation of Primary Endometriotic Stromal Cells for In Vitro Model Development - EMJ

Phenotypic and Functional Characterisation of Primary Endometriotic Stromal Cells for In Vitro Model Development EMJ

Published: April 30, 2026, 6:44 a.m.
Read Full Article
Transcriptomic Stratification of Advanced Primary Endometrial Tumours According to Mismatch Repair Status - EMJ

Transcriptomic Stratification of Advanced Primary Endometrial Tumours According to Mismatch Repair Status EMJ

Published: April 30, 2026, 6:24 a.m.
Read Full Article
Why endometriosis diagnosis takes so long: Primary care gaps, stigma, referral hurdles - Medical Xpress

Why endometriosis diagnosis takes so long: Primary care gaps, stigma, referral hurdles Medical Xpress

Published: April 22, 2026, 8:40 p.m.
Read Full Article
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - BioSpace

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer BioSpace

Published: Feb. 4, 2026, 4:47 a.m.
Read Full Article
Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer - TradingView

Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer TradingView

Published: Feb. 3, 2026, 1:11 p.m.
Read Full Article
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Newswire Canada

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Newswire …

Published: Feb. 3, 2026, 1 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!